How much is Velorum Therapeutics worth in 2026?

Velorum Therapeutics has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has Velorum Therapeutics raised?

Velorum Therapeutics has raised N/A in total funding across 1 funding rounds.

Velorum Therapeutics

Drug Discovery

Velorum Therapeutics valuation and funding history | Last updated: May 1, 2024 | 1 funding rounds

Current Valuation

N/A

As of May 1, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC

Amount undisclosed

Last Funding

May 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 1, 2024	Early Stage VC	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Velorum Therapeutics is currently valued at N/A as of May 1, 2024.

Track Velorum Therapeutics Valuation Updates

Get notified when Velorum Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Velorum Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Velorum Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Velorum Therapeutics Worth in 2026?

Velorum Therapeutics is a leading private company in the Drug Discovery sector. Track Velorum Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Velorum Therapeutics Valuation is Determined

Private company valuations like Velorum Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.